ALXO
Price
$0.46
Change
+$0.02 (+4.55%)
Updated
Jul 3 closing price
Capitalization
24.59M
32 days until earnings call
BCYC
Price
$7.44
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
514.56M
25 days until earnings call
Interact to see
Advertisement

ALXO vs BCYC

Header iconALXO vs BCYC Comparison
Open Charts ALXO vs BCYCBanner chart's image
ALX Oncology Holdings
Price$0.46
Change+$0.02 (+4.55%)
Volume$235.62K
Capitalization24.59M
Bicycle Therapeutics
Price$7.44
Change-$0.00 (-0.00%)
Volume$12
Capitalization514.56M
ALXO vs BCYC Comparison Chart in %
Loading...
ALXO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALXO vs. BCYC commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALXO is a Hold and BCYC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (ALXO: $0.46 vs. BCYC: $7.43)
Brand notoriety: ALXO and BCYC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALXO: 47% vs. BCYC: 48%
Market capitalization -- ALXO: $24.59M vs. BCYC: $514.56M
ALXO [@Biotechnology] is valued at $24.59M. BCYC’s [@Biotechnology] market capitalization is $514.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALXO’s FA Score shows that 0 FA rating(s) are green whileBCYC’s FA Score has 1 green FA rating(s).

  • ALXO’s FA Score: 0 green, 5 red.
  • BCYC’s FA Score: 1 green, 4 red.
According to our system of comparison, BCYC is a better buy in the long-term than ALXO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALXO’s TA Score shows that 3 TA indicator(s) are bullish while BCYC’s TA Score has 6 bullish TA indicator(s).

  • ALXO’s TA Score: 3 bullish, 7 bearish.
  • BCYC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than ALXO.

Price Growth

ALXO (@Biotechnology) experienced а +1.66% price change this week, while BCYC (@Biotechnology) price change was +2.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ALXO is expected to report earnings on Aug 07, 2025.

BCYC is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($515M) has a higher market cap than ALXO($24.6M). BCYC YTD gains are higher at: -46.929 vs. ALXO (-72.449). ALXO has higher annual earnings (EBITDA): -127.45M vs. BCYC (-200.61M). BCYC has more cash in the bank: 793M vs. ALXO (97.8M). BCYC has less debt than ALXO: BCYC (8.33M) vs ALXO (9.97M). BCYC has higher revenues than ALXO: BCYC (25.7M) vs ALXO (0).
ALXOBCYCALXO / BCYC
Capitalization24.6M515M5%
EBITDA-127.45M-200.61M64%
Gain YTD-72.449-46.929154%
P/E RatioN/AN/A-
Revenue025.7M-
Total Cash97.8M793M12%
Total Debt9.97M8.33M120%
FUNDAMENTALS RATINGS
BCYC: Fundamental Ratings
BCYC
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
32

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALXOBCYC
RSI
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
85%
Aroon
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ALXO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEEFX81.150.91
+1.13%
T. Rowe Price Tax-Efficient Equity I
FEYCX28.100.14
+0.50%
Fidelity Advisor Asset Manager 85% C
HRITX13.230.06
+0.46%
Hood River International Opportunity Ret
RSMVX10.880.04
+0.37%
William Blair Small-Mid Cap Value R6
FAOCX35.440.12
+0.34%
Fidelity Advisor Overseas C

ALXO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALXO has been loosely correlated with MDGL. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALXO jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALXO
1D Price
Change %
ALXO100%
+3.39%
MDGL - ALXO
56%
Loosely correlated
-0.43%
AXON - ALXO
45%
Loosely correlated
+2.70%
AMRN - ALXO
43%
Loosely correlated
+0.48%
ALNY - ALXO
39%
Loosely correlated
+0.65%
VERA - ALXO
36%
Loosely correlated
N/A
More